Aurora Analytica AS Secures Seed Funding to Fuel Product Development.
Oslo, Norway, 16th January 2024 – Aurora Analytica, a pioneering healthcare analytics data company, has successfully raised an undisclosed amount in seed funding. The funding will be used to accelerate the company's ongoing product development efforts and strengthen its position in the healthcare research sector.
Since its inception, Aurora Analytica has been at the forefront of healthcare innovation, providing cutting-edge research services to health pioneers and institutions striving to push the boundaries of clinical breakthroughs. The recent investment marks a significant milestone for the company as it continues to expand its capabilities and offerings.
"We are thrilled to announce the successful completion of our seed funding round," said Bhavish Lekh, CEO & Founder of Aurora Analytica. "This investment is a testament to the dedication and expertise of our team, as well as the potential of our advanced analytics solutions to drive transformative changes in healthcare research."
Aurora Analytica's mission is to empower healthcare professionals, researchers, and institutions with actionable insights derived from comprehensive data analysis. By harnessing the power of advanced analytics, the company enables stakeholders to make informed decisions that can lead to improved patient outcomes and ground-breaking medical advancements.
The seed funding round was led by Ola Gudmundsen at ERM Investments. Ola is an esteemed business leader and entrepreneur in the clinical trial services and health sector. Ola expressed confidence in Aurora Analytica's vision and potential to reshape the landscape of healthcare analytics.
"We believe that Aurora Analytica has the potential to revolutionize how healthcare data is analysed and utilized," said Ola Gudmundsen, from ERM Investments.
With the newly acquired funds, Aurora Analytica will further enhance its proprietary analytics platform the Aurora Suite™, expand its team of experts, and forge strategic collaborations with key players in the healthcare ecosystem. The company remains committed to advancing medical research and contributing to the development of innovative solutions that have a positive and lasting effect on patient care.
Aurora Analytica Secures Seed Funding to Fuel Product Development
For media inquiries and further information, please contact:
Bhavish Lekh, CEO & Founder
About Aurora Analytica AS:
Aurora Analytica AS is a leading healthcare analytics data company dedicated to transforming healthcare research through advanced data analysis. By providing state-of-the-art research services and actionable insights, the company supports health pioneers and institutions in their quest to achieve ground-breaking clinical advancements. For more information, visit auroraanalytica.com.
